HoldsUp

Dr. Tyna Moore · 2026-05-29 · Tyna Moore (host), Angelo Keely

Muscle, Protein & Perimenopause: The Truth About Midlife Weight Gain | KION

26 research-tied claims examined: 6 contradicted 6 overstated 12 supported 2 unverified

12 Supported by research
0:07:15Tyna Moore (host)supportedhigh

The loss of estrogen from the body makes a person more insulin resistant.

"and the lack of estrogen leaving the body makes you more insulin resistant." (said at 0:07:15)

Estrogen plays a key role in maintaining glucose homeostasis and insulin sensitivity. Clinical evidence, including a systematic review and meta-analysis of randomized controlled trials in postmenopausal women, demonstrates that estrogen deficiency increases insulin resistance, while estrogen replacement therapy significantly improves insulin sensitivity (measured by reduced HOMA-IR). Mechanistic and observational studies similarly confirm that declining estrogen levels drive impaired glucose tolerance and hepatic insulin resistance.

0:25:56Angelo Keelysupportedhigh

American society as a whole is much more overweight than it was 50 years ago.

"So even people, you know, if you look at all of society, I think in general, basically all of American society is much more overweight than it was 50 years ago." (said at 0:25:56)

Nationally representative surveillance data from the National Health Examination Survey (NHES) and the National Health and Nutrition Examination Survey (NHANES) demonstrate a substantial, multi-decade increase in body mass index (BMI), obesity, and severe obesity in the United States over the past 50 to 60 years. In the 1960s and early 1970s, adult obesity prevalence was approximately 13% to 15%, whereas recent NHANES surveys (2017–2023) show adult obesity prevalence exceeding 40% and overall overweight/obesity prevalence surpassing 70%.

0:29:21Tyna Moore (host)supportedlow

Breast milk produced by obese mothers has neurological impacts on the infant's brain.

"Even the milk that is produced by obese mothers has neurological impacts in the brain of the baby." (said at 0:29:21)

Evidence from human cohort studies and animal models demonstrates that maternal obesity significantly alters the nutritional and bioactive composition of breast milk—including reduced levels of critical omega-3 fatty acids like docosahexaenoic acid (DHA), elevated omega-6:omega-3 ratios, and altered levels of inflammatory cytokines, insulin, and leptin. In prospective human studies (such as the PREOBE follow-up cohort), these obesity-related alterations in breast milk fatty acid profiles were associated with differences in infant cognitive development scores. Animal lactation models also confirm that milk from obese dams directly induces hypothalamic leptin and insulin signaling alterations in developing offspring. However, certainty is rated as low due to the observational nature of human infant neurodevelopmental data and reliance on animal experimental models.

0:49:02Angelo Keelysupportedmoderate

NASA-sponsored bed rest studies at the University of Texas Medical Branch found that subjects placed on complete bed rest for 28 days at maintenance calories had no average muscle loss when supplemented with leucine-enriched essential amino acids.

"there were multiple studies sponsored through the University of Texas Medical Branch where they had people at complete bed rest for 28 days consuming a normal diet, so it was not a caloric deficit. Um they consumed a normal diet at maintenance calories, but no movement for 28 days, and they were given leucine-enriched essential amino acids multiple times a day. And there was a there uh the mean average of the group in general was no muscle loss." (said at 0:49:02)

In a randomized trial conducted at the University of Texas Medical Branch and supported by NASA, healthy subjects placed on strict bed rest for 28 days on a maintenance energy diet received leucine-enriched essential amino acid and carbohydrate supplementation three times daily between meals. The supplemented group experienced no average loss of lean leg mass (+0.2 ± 0.3 kg) compared to the unsupplemented control group (-0.4 ± 0.1 kg).

0:59:45Angelo Keelysupportedmoderate

In 60-year-old women, consuming 3 grams of essential amino acids containing 40% leucine stimulates as much muscle protein synthesis as 20 grams of whey protein.

"in these studies, uh for example, just 3 g of essential amino acids, of which 40% was leucine... had the impact of 20 g of whey protein in women that were 60. Just 3 g. So not 3 g of leucine, 3 g of total essential amino acids so long as 40% of it was leucine." (said at 0:59:45)

A randomized controlled trial in older women (mean age 66 ± 2.5 years) directly compared a 3 g dose of leucine-enriched essential amino acids (containing 40% leucine, or 1.2 g leucine) to 20 g of bolus whey protein. The study evaluated muscle protein synthesis (MPS) via stable isotope tracer infusion at rest and following resistance exercise, finding that the 3 g leucine-enriched EAA formulation stimulated muscle protein synthesis equally to the 20 g of whey protein over 0–2 hours at rest and remained equivalently elevated over 0–4 hours when combined with exercise.

0:48:35Angelo Keelysupportedmoderate

GLP-1 receptor agonist medications improve HbA1c and lower LDL cholesterol through mechanisms independent of weight loss.

"they're seeing that LDL is lowering, A1C is lowering, like all these things are getting better that they don't even fully understand like why and how yet that are independent of weight loss." (said at 0:48:35)

Clinical trial data and pooled analyses demonstrate that glucagon-like peptide-1 (GLP-1) receptor agonists (and dual incretin agonists) improve glycemic control (HbA1c) and lipid parameters through direct incretin mechanisms that occur independently of weight change, although greater weight reduction confers additive improvements.

0:52:20Tyna Moore (host)supportedhigh

Unintentional body weight loss of greater than 10% during an acute illness or cancer is associated with significantly elevated morbidity and mortality.

"usually what I was taught in medicine, if somebody loses more than 10% of their body weight due to an illness or an episode of illness, um they're screwed. Like that's bad. That's bad news. And when we see somebody with cancer lose more than 10% of their body weight or we see somebody with COVID or a virus with lose more than 10% of their body weight, we're like—I mean, that's when the alarms go off" (said at 0:52:20)

Unintentional weight loss during serious acute illness or malignancy is a well-established prognostic indicator of substantially increased morbidity and mortality. International clinical consensus defines cancer cachexia starting at unintentional weight loss greater than 5% (or >2% in already depleted individuals). Large observational studies in cancer patients demonstrate that weight loss exceeding 10% is strongly and independently associated with markedly reduced overall survival across cancer types and stages.

0:58:30Angelo Keelysupportedhigh

In whey protein powder, essential amino acids make up only approximately 45% of the total protein content.

"even in a whey protein powder, which is an awesome protein source, and steak is an awesome protein source, only about 45%, less than half of the protein is actually the essential amino acids" (said at 0:58:30)

Analytical profiles of dietary protein sources confirm that essential amino acids (EAAs) comprise approximately 43% to 50% of the total protein in whey protein, meaning less than half of the amino acid content consists of EAAs while the remainder consists of non-essential amino acids.

1:10:10Angelo Keelysupportedmoderate

Taking essential amino acids prior to exercise increases the delivery of amino acids into muscle tissue due to increased exercise-induced blood flow.

"But on days when I'm training or during any type of like intense exercise, I also take it before I exercise because the increased blood flow moves more of the essential amino acids into the muscle. HOST: Ah. GUEST1: And there's a very important synergistic effect where you get that much more benefit from the exercise." (said at 1:10:10)

The claim is supported by clinical research evaluating the timing of essential amino acid (EAA) ingestion relative to exercise. Tipton et al. (2001) demonstrated that consuming essential amino acids and carbohydrates immediately prior to resistance exercise resulted in a significantly greater delivery of amino acids to muscle tissue during and after exercise compared to post-exercise ingestion, driven by increased exercise-induced hyperemia (blood flow), leading to a superior net muscle protein synthesis response.

1:20:13Angelo Keelysupportedmoderate

Reductions in all-cause mortality, cancer, dementia, and heart disease are associated with raising the red blood cell omega-3 index from 4% to 8%.

"when you look at like kind of the reduction to all-cause mortality and reduction in specific cases of like cancer, dementia, heart disease, all these things, it's about getting your omega-3 levels in your red blood cells up from like 4% to 8%." (said at 1:20:13)

The Omega-3 Index measures the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in red blood cell (RBC) membranes. A level below 4% is established in the literature as high risk, while a level of 8% or greater is established as the optimal cardioprotective target. Large prospective cohort analyses (including the Framingham Heart Study and the Fatty Acid and Outcome Research Consortium [FORCE]) demonstrate that higher RBC omega-3 status (e.g., highest vs. lowest quintiles, corresponding roughly to >6.8–8% vs. <4%) is inversely associated with all-cause mortality (approximately 17–34% lower risk) and cardiovascular disease events and mortality (approximately 21–39% lower risk), as well as reductions in cancer mortality and risk for neurodegenerative decline. Because these targets are derived primarily from prospective observational cohorts, these relationships represent robust epidemiologic associations rather than proven causal outcomes from randomized intervention trials.

1:20:30Angelo Keelysupportedhigh

A daily intake of 3 grams of omega-3 fatty acids generally raises red blood cell omega-3 levels from 4% to 8%, and the standard pharmaceutical treatment dose is about 4 grams per day.

"But what I would say is generally if you're taking about 3 grams a day, you know, I think the um the pharmaceutical dose is like 4 grams a day when they're actually treating people. But 3 grams a day consistently, you are basically, you know, very likely to get to those higher levels." (said at 1:20:30)

The claim accurately describes both the effect of daily omega-3 supplementation on red blood cell omega-3 levels (the Omega-3 Index) and standard prescription omega-3 dosing. Research modeling dose-response across 14 clinical trials shows that supplementing with approximately 2 g to 3 g daily of EPA/DHA reliably increases red blood cell EPA+DHA levels from average baseline levels (~4.9%) up to targeted cardio-protective levels of around 8% or higher (PMID 31396625). Furthermore, scientific guidelines from the American Heart Association confirm that standard pharmaceutical prescription omega-3 treatments (such as Lovaza or Vascepa) are administered at a therapeutic dose of 4 g/day for clinical indications like severe hypertriglyceridemia (PMID 31422671).

1:20:55Angelo Keelysupportedmoderate

Omega-3 fatty acids incorporate into cell membranes, making red blood cells more flexible.

"Omega-3s basically make your blood cells and everything much more flexible. And so when you can get it to be made up of more of that than these kind of stricter, harder fats, um it has, you know, these amazing benefits." (said at 1:20:55)

Omega-3 polyunsaturated fatty acids (such as EPA and DHA) readily incorporate into cell membrane phospholipids, displacing more rigid saturated fatty acids and increasing membrane fluidity. In animal and pathological models (such as sickle cell disease), DHA supplementation significantly reduces red blood cell (RBC) stiffness and enhances deformability. In human trials, omega-3 supplementation consistently increases membrane omega-3 content and improves the deformability of leukocytes, although in healthy subjects with baseline-flexible erythrocytes, detectable changes in RBC deformability can be subtle or vary depending on the measurement technique.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.